Prime Minister Boris Johnson leaves Downing Street in London, Britain, March 24 2021. Picture: REUTERS/JOHN SIBLEY
Prime Minister Boris Johnson leaves Downing Street in London, Britain, March 24 2021. Picture: REUTERS/JOHN SIBLEY

London — Capitalism and greed gave Britain its success in vaccinating its population, Prime Minister Boris Johnson told MPs in a closed meeting, a remark that could rile up Brussels at a time when Britain faces an EU threat to block vaccine imports.

“The reason we have the vaccine success is because of capitalism, because of greed my friends,” The Sun newspaper quoted Johnson as telling Conservative MPs during a Zoom meeting on Tuesday evening.

Johnson then tried to row back and said: “Actually, I regret saying it,” and then asked MPs repeatedly to “forget I said that”.

Britain has so far mounted the fastest Covid-19 vaccine programme of any big country. But it now finds its programme threatened by the EU, which has been far slower in rolling out vaccines and faces a third wave of infections.

The European Commission is expected on Wednesday to extend powers to block exports, a move that could hit supply of doses bound for Britain. Johnson's remarks come after a week in which British ministers have tried to calm the row.

Downing Street declined to comment on Johnson's remarks when contacted by Reuters, but unidentified sources gave the BBC a bizarre array of explanations.

The greed comment, according to the BBC's political editor Laura Kuenssberg, was apparently a joke about one of his cabinet colleagues, chief whip Mark Spencer.

Johnson, home secretary Priti Patel said, was talking about the success of pharmaceutical companies in developing a vaccine shot in record time.

“Clearly the prime minister was actually referring to the work that has taken place with pharmaceutical companies and how we have led the way really in this vaccine development,” said Patel, who was not in the meeting.

Britain was one of several countries that developed a Covid-19 vaccine shot in record time: the shot developed by Oxford University and AstraZeneca was approved for use on December 30 by the British medicines regulator.

The British government helped fund the research, and AstraZeneca has promised to market it on a not-for-profit basis.

Other vaccines have been developed with state funding, including in China and Russia and the US.

Reuters 

Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.